Cyclerion Therapeutics Inc. (CYCN)
NASDAQ · Healthcare
Cyclerion Therapeutics Inc. Net Income 2019–2025
Cyclerion Therapeutics Inc. annual/quarterly net income history and growth rate from 2019 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Cyclerion Therapeutics Inc. net income for the quarter ending March 31, 2026 was -3.2 M, a 122.32% increase year-over-year.
- Cyclerion Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -5.9 M, a 248.43% decrease year-over-year.
- Cyclerion Therapeutics Inc. annual net income for 2025 was -3.5 M, a 15.41% increase from 2024.
- Cyclerion Therapeutics Inc. annual net income for 2024 was -3.1 M, a 41.92% decrease from 2023.
- Cyclerion Therapeutics Inc. annual net income for 2023 was -5.3 M, a 88.06% decrease from 2022.
- Cyclerion Therapeutics Inc. annual net income for 2022 was -44.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cyclerion Therapeutics Inc. Net Income — FAQ
Cyclerion Therapeutics Inc. (CYCN) net income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Cyclerion Therapeutics Inc.'s net income?
Cyclerion Therapeutics Inc. (CYCN) reported net income of -$4M for fiscal 2025.
Where can I see CYCN's net income history?
The chart and table above show Cyclerion Therapeutics Inc.'s net income by year and by quarter, including the growth rate.